Capillary deposition of the complement fragment C4d in cardiac allograft biopsies is associated with a allograft vasculopathy

Transplant International

Volumn 18, Issue 3, 2005, Pages 313-317

  Poelzl, Gerhard ^a   Ullrich, Robert ^b   Huber, Andreas ^a   Ulmer, Hanno ^a   Antretter, Herwig ^a   Hoefer, Daniel ^a   Mairinger, Thomas ^a   Laufer, Guenther ^a   Pachinger, Otmar ^a   Schwarzacher, Severin ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Coronary disease; Endomyocardial biopsy; Immunohistochemisitry; Transplantation

Indexed keywords

AZATHIOPRINE; COMPLEMENT COMPONENT C4D; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; PEPTIDE FRAGMENT;

ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; ALLOTRANSPLANTATION; BIOPSY; CAPILLARY; CORONARY ARTERY DISEASE; HEART MUSCLE; METABOLISM; PATHOLOGY;

BIOPSY; CAPILLARIES; COMPLEMENT ACTIVATION; COMPLEMENT C4B; CORONARY DISEASE; HEART TRANSPLANTATION; HUMANS; MYOCARDIUM; PEPTIDE FRAGMENTS; TRANSPLANTATION, HOMOLOGOUS;

EID: 20844452888     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2004.00037.x     Document Type: Article

References (12)

1. Yeung AC, Davis SF, Hauptman PJ, et al. Incidence and progression of transplant coronary artery disease over 1 year: results of a multicenter trial with use of intravascular ultrasound. J Heart Lung Transplant 1995; 14: S215.
2. Baldwin WM III, Qian Z, Ota H, et al. Complement as a mediator of vascular inflammation and activation in allografts. J Heart Lung Transplant 2000; 19: 723.
3. Baldwin WM III, Samaniego-Picota M, Kasper EK, et al. Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes. Transplantation 1999; 68: 894.
4. Behr TM, Feucht HE, Richter K, et al. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant 1999; 18: 904.
5. Billingham ME, Gary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Transplant 1990; 9: 587.
6. Olson SL, Wagoner LE, Hammond EH, et al. Vascular rejection in heart transplantation: clinical correlation, treatment options, and future considerations. J Heart Lung Transplant 1993; 12: S135.
7. Böhmig GA, Exner M, Habicht A, et al. Capillary C4d deposition of in kidney allografts: a specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 2002; 12: 1091.
8. Qian Z, Hu W, Liu J, Sanfilippo F, Hruban RH, Baldwin WM III. Accelerated graft arteriosclerosis in cardiac transplants: complement activation promotes progression of lesions in from medium to large arteries. Transplantation 2001; 72: 900.
9. Labarrere CA, Nelson DR, Faulk WP. Myocardial fibrin deposits in the first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipients. Am J Med 1998; 105: 207.
10. Vallhonrat H, Williams WW, Dec GE, et al. Complement activation products in plasma after heart transplantation in humans. Transplantation 2001; 71: 1308.
11. Hammond MEH, Renlund DG. Cardiac allograft (microvascular) rejection. Curr Opin Organ Transplant 2002; 7: 233.
12. Michaels PJ, Espejo ML, Kobashigawa J, et al. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Transplant 2003; 22: 58.